Obesity, metabolic syndrome and dyslipidemia may be linked to intravascular lipolysis, anti-lipolytic effect of insulin, adipose tissue resistance and insulin resistance in peripheral tissues leading to an enhanced hepatic flux of fatty acids from dietary sources [23] and significantly associated with myocardial infarction risk among men [6]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.